Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Digestive Diseases and Sciences
Published in: Digestive Diseases and Sciences 1/2016

01-01-2016 | Review

Dumping Syndrome: A Review of the Current Concepts of Pathophysiology, Diagnosis, and Treatment

Authors: Patrick Berg, Richard McCallum

Published in: Digestive Diseases and Sciences | Issue 1/2016

Login to get access

Abstract

Gastric surgery has long been known to be a cause of dumping syndrome (DS). However, the increasing incidence of gastric bypass surgery, as well as reports of DS unrelated to previous gastric surgeries, has increased the importance of understanding DS in recent years. DS is due to the gastrointestinal response to voluminous and hyperosmolar chyme that is rapidly expelled from the stomach into the small intestine. This response involves neural and hormonal mechanisms. This review encompasses the symptoms, diagnosis, and treatment approaches of DS and also focuses on the current research status of the pathophysiology of DS.
Literature
1.
Pinatel LF. Peptic ulcer: late complications of the surgical treatment. Rev Gastroenterol Peru. 1995;15:273–281.
2.
Tack J, Arts J, Caenepeel P, et al. Pathophysiology, diagnosis and management of postoperative dumping syndrome. Nat Rev Gastroenterol Hepatol. 2009;6:583–590.PubMedCrossRef
3.
Behrns KE, Sarr MG. The early postprandial dumping syndrome: prevention and treatment. Adv Surg. 1994;27:233–255.PubMed
4.
Eagon JC, Miedema BW, Kelly KA. Postgastrectomy syndromes. Surg Clin North Am. 1992;72:445–465.PubMed
5.
Mechanick JI, Youdim A, Jones DB, et al. Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient—2013 update: cosponsored by American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic & Bariatric Surgery. Surg Obes Relat Dis. 2013;9:159–191.PubMedCrossRef
6.
Berg, et al. Dumping syndrome, updated perspectives on etiologies and diagnosis. Pract Gastroenterol. 2014;38:30–38.
7.
Plavšić I, Hauser G, Tkalčić M, Pletikosić S, Salkić N, Diagnosis of irritable bowel syndrome: role of potential biomarkers. Gastroenterol Res Pract. 2015; 490183. Epub. 6/11/2015.
8.
van der Kleij F, Vecht J, Lamers C, et al. Diagnostic value of dumping provocation in patients after gastric surgery. Scand J Gastroenterol. 1996;31:1162–1166.PubMedCrossRef
9.
Tougas G, Eaker EY, Abell TL, et al. Assessment of gastric emptying using a low fat meal: establishment of international control values. Am J Gastroenterol. 2000;95:1456–1462.PubMedCrossRef
10.
Gulsrud PO, Taylor IL, Watts HD, et al. How gastric emptying of carbohydrate affects glucose tolerance and symptoms after truncal vagotomy with pyloroplasty. Gastroenterology. 1980;78:1463–1471.PubMed
11.
Aldoori MI, Qamar MI, Read AE, et al. Increased flow in the superior mesenteric artery in dumping syndrome. Br J Surg. 1985;72:389–390.PubMedCrossRef
12.
Lipsitz LA, Ryan SM, Parker JA, et al. Hemodynamic and autonomic nervous system responses to mixed meal ingestion in healthy young and old subjects and dysautonomic patients with postprandial hypotension. Circulation. 1993;87:391–400.PubMedCrossRef
13.
Jansen RW, Penterman BJ, van Lier HJ, et al. Blood pressure reduction after oral glucose loading and its relation to age, blood pressure and insulin. Am J Cardiol. 1987;60:1087–1091.PubMedCrossRef
14.
Heseltine D, Potter JF, Hartley G, et al. Blood pressure, heart rate and neuroendocrine responses to a high carbohydrate and a high fat meal in healthy young subjects. Clin Sci (Lond). 1990;79:517–522.CrossRef
15.
Fagius J, Berne C. Increase in muscle nerve sympathetic activity in humans after food intake. Clin Sci (Lond). 1994;86:159–167.CrossRef
16.
LeQuesne LP, Hobsley M, Hand BH. The Dumping Syndrome- 1. Factors responsible for symptoms. Br Med J. 1960;1:141.CrossRef
17.
Zhao XT, Wang L, Lin HC. Slowing of intestinal transit by fat depends on naloxone-blockable efferent, opioid pathway. Am J Physiol Gastrointest. 2000;278:G866–G870.
18.
Sarr MG, Foley MK, Winters RC, et al. Role of extrinsic innervation in carbohydrate-induced ileal modulation of pancreatic secretion and upper gut function. Pancreas. 1997;14:166–173.PubMedCrossRef
19.
Fu-Cheng X, Anini Y, Chariot J, et al. Peptide YY release after intraduodenal, intraileal, and intracolonic administration of nutrients in rats. Pflugers Arch. 1995;431:66–75.PubMedCrossRef
20.
Pedersen JH, Beck H, Shokouh-amiri M, et al. Effect of neurotensin in the dumping syndrome. Scand J Gastroenterol. 1986;21:478–482.PubMedCrossRef
21.
Lawaetz O, Blackburn AM, Bloom SR, et al. Gut hormone profile and gastric emptying in the dumping syndrome: a hypothesis concerning the pathogenesis. Scand J Gastroenterol. 1983;18:73–80.PubMedCrossRef
22.
Sagor GR, Bryant MG, Ghatei MA, et al. Release of vasoactive intestinal peptide in the dumping syndrome. BMJ (Clin Res Ed). 1981;282:507–510.CrossRef
23.
Fahrenkrug J, Haglund U, Jodal M, et al. Nervous release of vasoactive intestinal polypeptide in the gastrointestinal tract of cats: possible physiological implications. J Physiol. 1978;284:291–305.PubMedPubMedCentralCrossRef
24.
Gebhard B, Holst JJ, Biegelmayer C, et al. Postprandial GLP-1, norepinephrine, and reactive hypoglycemia in dumping syndrome. Dig Dis Sci. 2001;46:1915–1923.PubMedCrossRef
25.
Schirra J, Goke B. The physiological role of GLP-1 in human: incretin, ileal brake or more. Regul Pept. 2005;128:109–115.PubMedCrossRef
26.
Yamamoto H, Kishi T, Lee CE, et al. Glucagon-like peptide-1-responsive catecholamine neurons in the area postrema link peripheral glucagon-like peptide-1 with central autonomic control sites. J Neurosci. 2003;1:2939–2946.
27.
Yamamoto H, Mori T, Tsuchihashi H, et al. A possible role of GLP-1 in the pathophysiology of early dumping syndrome. Dig Dis Sci. 2005;50:2263–2267.PubMedCrossRef
28.
Lin HC, Neevel C, Chen PS, Suh G, Chen JH. Slowing of intestinal transit by fat or peptide YY depends on beta-adrenergic pathway. Am J Physiol Gastrointest. 2003;285:G1310–G1316.CrossRef
29.
Berg P, Hall M, Sarosiek I, et al. Understanding the etiologies, clinical spectrum, and diagnostic challenge of dumping syndrome. Gastroenterology. 2013;144:S-734.CrossRef
30.
Kitagawa Y, Dempsey DT. Stomach. In: Brunicardi FC, Andersen DK, Timothy RB, et al., eds. Schwartz’s Principles of Surgery. 10th ed. United States of America: McGraw Hill Education; 2015:1062.
31.
32.
Mallory GN, Macgregor AM, Rand CS. The influence on dumping on weight loss after gastric restrictive surgery for morbid obesity. Obes Surg. 1996;6:474–478.PubMedCrossRef
33.
Abell TL, Minocha A. Gastrointestinal complications of bariatric surgery: diagnosis and therapy. Am J Med Sci. 2006;331:214–218.PubMedCrossRef
34.
Lugo-Vicente H. Dumping syndrome. Pediatric Surgery Update. 2000;14:1.
35.
Schauer PR, Bruce S. The surgical management of obesity. In: Brunicardi FC, Andersen DK, Timothy RB, et al., eds. Schwartz’s principles of surgery. 10th ed. United States of America: McGraw Hill Education; 2015:1121.
36.
Hejazi RA, Patil H, McCallum RW. Dumping syndrome: establishing criteria for diagnosis and identifying new etiologies. Dig Dis Sci. 2010;55:117–123.PubMedCrossRef
37.
Didden P, Penning C, Masclee AAM. Octreotide therapy in dumping syndrome: analysis of long-term results. Aliment Pharmacol Ther. 2006;24:1367–1375.PubMedCrossRef
38.
Leeds AR, Ralphs DN, Ebied F, et al. Pectin in the dumping syndrome: reduction of symptoms and plasma volume changes. Lancet. 1981;1:1075–1078.
39.
De Cunto A, Barbi E, Minen F, et al. Safety and efficacy of high-dose acarbose treatment for dumping syndrome. J Pediatr Gastroenterol Nutr. 2011;53:113–114.PubMedCrossRef
40.
Hasegawa T, Yoneda M, Nakamura K, et al. Long-term effect of alpha-glycosidase inhibitor on late dumping syndrome. J Gastroenterol Hepatol. 1998;13:1201–1206.PubMed
41.
Parrish CR. The clinician’s guide to short bowel syndrome. Pract Gastroenterol. 2005;29:67.
42.
43.
Spanakis E, Gragnoli. Successful medical management of status post-Roux-en-Y-gastric-bypass hyperinsulinemic hypoglycemia. Obes Surg. 2009;19:1333–1334.PubMedPubMedCentralCrossRef
44.
Li-Ling J, Irving M. Therapeutic value of octreotide for patients with severe dumping syndrome—a review of randomised controlled trials. Postgrad Med J. 2001;77:441–442.PubMedPubMedCentralCrossRef
45.
Hasler WL, Soudah HC, Owyang C. Mechanisms by which octreotide ameliorates symptoms in the dumping syndrome. J Pharmacol Exp Ther. 1996;277:1359–1365.PubMed
46.
Vecht J, Lamers CB, Masclee AA. Long-term results of octreotide-therapy in severe dumping syndrome. Clin Endocrinol (Oxf). 1999;51:619–624.CrossRef
Metadata
Title
Dumping Syndrome: A Review of the Current Concepts of Pathophysiology, Diagnosis, and Treatment
Authors
Patrick Berg
Richard McCallum
Publication date
01-01-2016
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 1/2016
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-015-3839-x

Other articles of this Issue 1/2016

Digestive Diseases and Sciences 1/2016 Go to the issue

Original Article

Predictors of Thiopurine Treatment Failure in Biologic-Naïve Ulcerative Colitis Patients

Erratum

Erratum to: Trimethylamine-N-oxide: A Novel Biomarker for the Identification of Inflammatory Bowel Disease

Original Article

Reduced Risk of Barrett’s Esophagus in Statin Users: Case–Control Study and Meta-Analysis

Original Article

Outcomes of Next-Day Versus Non-next-Day Colonoscopy After an Initial Inadequate Bowel Preparation

Original Article

Sense of Coherence and Defense Style Predict Sleep Difficulties in Early Non-metastatic Colorectal Cancer

UNM Clinical Case Conferences

Obscure Occult GI Bleeding: An Iatrogenic Tale?
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits